Early ARDS Risk Modeling: Volv Global’s machine-learning model flags community-acquired pneumonia patients likely to progress to ARDS up to five days early, validated on independent ICU data and aligned with expert chart reviews. Cardiac Procedure Reduction: Heartflow’s FUSION trial reports that adding FFRCT to standard coronary CT cuts unnecessary invasive catheter procedures by 44% in a government-funded randomized study. Medical Delivery Safety Watch: A new mouse study compares engineered AAV capsids for better blood–brain barrier access, while showing even “brain-targeted” vectors can persist in organs like the liver. Biotech Partnerships: Henlius and Sandoz expand a biosimilars deal covering about 10 monoclonal antibody/ADC products, with rights outside China. Longevity Wearables Move: Temple acquires London’s Longevous to bolster clinical and scientific depth ahead of its wearable launch. Climate & Disaster Engineering: China warns of high risk that a Nepal-Tibet barrier lake could breach again after deadly floods, sending teams to model and monitor drainage options. Sustainable Materials: Chlorine-free processing using peracetic acid turns sugar beet pulp into cellulose nanofibers, aiming to cut toxic bleaching by-products. Cybersecurity in Healthcare: Multiple reports highlight Boston Scientific’s cyberattack disrupting medical device order processing and shipments. STEM & Skills: IIT Delhi opens an online Advanced Data Analytics in Management program, while Gujarat launches India’s first state sports genomics effort to guide athlete development.